{"doi":"10.1038/s41541-024-00896-y","title":"Differential long-term bivalent HPV vaccine cross-protection by variants in the Costa Rica HPV vaccine trial","abstract":"The AS04-adjuvanted human papillomavirus (HPV)16/18 vaccine, an L1-based vaccine, provides strong vaccine efficacy (VE) against vaccine-targeted type infections, and partial cross-protection to phylogenetically-related types, which may be affected by variant-level heterogeneity. We compared VE against incident HPV31, 33, 35, and 45 detections between lineages and SNPs in the L1 region among 2846 HPV-vaccinated and 5465 HPV-unvaccinated women through 11-years of follow-up in the Costa Rica HPV Vaccine Trial. VE was lower against HPV31-lineage-B (VE=60.7%;95%CI = 23.4%,82.8%) compared to HPV31-lineage-A (VE=94.3%;95%CI = 83.7%,100.0%) (VE-ratio = 0.64;95%CI = 0.25,0.90). Differential VE was observed at several lineage-associated HPV31-L1-SNPs, including a nonsynonymous substitution at position 6372 on the FG-loop, an important neutralization domain. For HPV35, the only SNP-level difference was at position 5939 on the DE-loop, with significant VE against nucleotide-G (VE=65.0%;95%CI = 28.0,87.8) but not for more the common nucleotide-A (VE=7.4%;95%CI = -34.1,36.7). Because of the known heterogeneity in precancer/cancer risk across cross-protected HPV genotype variants by race and region, our results of differential variant-level AS04-adjuvanted HPV16/18 vaccine efficacy has global health implications.","journal":"npj Vaccines","year":2024,"id":440515,"datarank":0.0,"base_score":0.0,"endowment":0.0,"self_citation_contribution":0.0,"citation_network_contribution":0.0,"self_endowment_contribution":0.0,"citer_contribution":0.0,"corpus_percentile":null,"corpus_rank":null,"citation_count":9,"citer_count":0,"citers_with_citation_signal":0,"citers_with_endowment":0,"datacite_reuse_total":0,"is_dataset":false,"is_dataset_confidence":0.9535,"is_data_producer":false,"deposit_databanks":null,"is_oa":true,"file_count":0,"downloads":0,"has_version_chain":false,"published_date":"2024-01-01","fair_score":null,"fair_percentile":null,"algorithm_id":"datarank_citation_only_1hop_v6","ranking_scope":"data_only","authors":[{"id":265750,"name":"Carolina Porras","orcid":"0000-0002-4592-3883","position":1,"is_corresponding":false},{"id":291028,"name":"Maísa Pinheiro","orcid":"0000-0002-9112-1179","position":2,"is_corresponding":false},{"id":265752,"name":"Rolando Herrero","orcid":"0000-0001-5448-3456","position":3,"is_corresponding":false},{"id":265756,"name":"Allan Hildesheim","orcid":"0000-0003-0257-2363","position":4,"is_corresponding":false},{"id":388041,"name":"Danping Liu","orcid":"0000-0001-5483-6303","position":5,"is_corresponding":false},{"id":265760,"name":"Mitchell H. Gail","orcid":"0000-0002-3919-3263","position":6,"is_corresponding":false},{"id":670291,"name":"Byron Romero","orcid":null,"position":7,"is_corresponding":false},{"id":264119,"name":"John T. Schiller","orcid":"0000-0001-7308-950X","position":8,"is_corresponding":false},{"id":669791,"name":"Michael Zúñiga","orcid":"0000-0002-8479-4965","position":9,"is_corresponding":false},{"id":588276,"name":"Sambit Kumar Mishra","orcid":"0000-0001-8319-0599","position":10,"is_corresponding":false},{"id":379937,"name":"Laurie Burdette","orcid":null,"position":11,"is_corresponding":false},{"id":264023,"name":"Kristine Jones","orcid":"0000-0003-1584-8920","position":12,"is_corresponding":false},{"id":265759,"name":"John Schussler","orcid":"0000-0002-8793-0766","position":13,"is_corresponding":false},{"id":265762,"name":"Rebeca Ocampo","orcid":"0000-0002-8069-5142","position":14,"is_corresponding":false},{"id":492479,"name":"Jianwen Fang","orcid":"0000-0002-6502-6004","position":15,"is_corresponding":false},{"id":291440,"name":"Zhiwei Liu","orcid":"0000-0002-0136-651X","position":16,"is_corresponding":false},{"id":218030,"name":"Douglas R. Lowy","orcid":"0000-0003-0635-219X","position":17,"is_corresponding":false},{"id":265751,"name":"Sabrina H. Tsang","orcid":"0000-0002-6445-4904","position":18,"is_corresponding":false},{"id":432802,"name":"Ana Cecilia Rodríguez","orcid":"0000-0001-6537-3199","position":19,"is_corresponding":false},{"id":69966,"name":"Mark Schiffman","orcid":"0000-0002-4625-2508","position":20,"is_corresponding":false},{"id":777120,"name":"Cameron B. Haas","orcid":"0000-0002-8211-0806","position":21,"is_corresponding":false},{"id":863133,"name":"Loretto J Carvajal","orcid":"0000-0002-4965-7615","position":22,"is_corresponding":false},{"id":1023085,"name":"Jalen Brown","orcid":"0000-0002-5149-3007","position":23,"is_corresponding":false},{"id":948069,"name":"Romain Fantin","orcid":"0000-0003-2906-3438","position":24,"is_corresponding":false},{"id":291037,"name":"Lisa Mirabello","orcid":"0000-0001-8485-0106","position":25,"is_corresponding":false},{"id":858509,"name":"Costa Rica HPV Vaccine Trial (CVT) Group","orcid":null,"position":26,"is_corresponding":false},{"id":268964,"name":"Bernal Cortés","orcid":null,"position":27,"is_corresponding":false},{"id":265767,"name":"Paula González","orcid":"0000-0003-0154-0087","position":28,"is_corresponding":false},{"id":268965,"name":"Silvia E. Jiménez","orcid":null,"position":30,"is_corresponding":false},{"id":265764,"name":"Ana Cecilia Rodríguez","orcid":"0000-0001-9866-2106","position":32,"is_corresponding":false},{"id":1928,"name":"Mark E. Sherman","orcid":"0000-0002-9222-8808","position":38,"is_corresponding":false},{"id":433395,"name":"Sholom Wacholder","orcid":null,"position":39,"is_corresponding":false},{"id":265768,"name":"Lígia A. Pinto","orcid":"0000-0002-3130-9882","position":40,"is_corresponding":false},{"id":265769,"name":"Troy J. Kemp","orcid":"0000-0002-1197-7525","position":41,"is_corresponding":false},{"id":268966,"name":"Mary Sidawy","orcid":null,"position":42,"is_corresponding":false},{"id":265761,"name":"Wim Quint","orcid":"0000-0001-8616-9410","position":43,"is_corresponding":false},{"id":268967,"name":"Leen‐Jan van Doorn","orcid":null,"position":44,"is_corresponding":false},{"id":265770,"name":"Linda Struijk","orcid":"0000-0001-9508-6924","position":45,"is_corresponding":false},{"id":265771,"name":"Joel M. Palefsky","orcid":"0000-0002-5097-3818","position":46,"is_corresponding":false},{"id":265754,"name":"Teresa M. Darragh","orcid":"0000-0002-4382-9949","position":47,"is_corresponding":false},{"id":265755,"name":"Mark H. Stoler","orcid":"0000-0002-2784-1008","position":48,"is_corresponding":false},{"id":521810,"name":"Jaimie Z. Shing","orcid":"0000-0001-7064-4424","position":0,"is_corresponding":true}],"reference_count":39,"raw_metadata":null,"created_at":"2026-07-19T02:01:01.842286Z","pmid":"38851816","pmcid":null,"fwci":null,"citation_percentile":null,"influential_citations":0,"oa_status":null,"license":null,"views":0,"total_file_size_bytes":0,"version_count":0,"fair_f":null,"fair_a":null,"fair_i":null,"fair_r":null,"fair_zscore":null,"fair_rationale":null,"fair_model":null,"fair_agent_version":null,"fair_fulltext_source":null,"fair_has_llm":null,"fair_computed_at":null,"clinical_trials":[],"software_tools":[],"db_accessions":[],"linked_datasets":[],"topics":[]}